{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:30:29Z","timestamp":1789047029766,"version":"build-2803163510"},"reference-count":24,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301502"],"award-info":[{"award-number":["82301502"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Brain and Behavior"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Information regarding the signaling axis involving triggering receptor expressed on myeloid cells 1 (TREM\u20101) and its downstream mediator, signal transducer and activator of transcription 3 (STAT3), remains limited in ischemic stroke. We investigated the plasma levels of TREM\u20101 in patients with ischemic stroke and compared to controls. Second, we investigated the potential correlation between plasma TREM\u20101 levels and STAT3 expression in peripheral blood mononuclear cells (PBMCs) and explored their associations with stroke severity and functional outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In an observational case\u2010control study, plasma and PBMCs from participants were collected to measure TREM\u20101 and STAT3 expression levels. The National Institutes of Health Stroke Scale (NIHSS) at admission, day 7, and 1 and 3 months, and the modified Rankin Scale (mRS) at 3 months post\u2010discharge were assessed. Plasma TREM\u20101 levels and STAT3 expression were measured by enzyme\u2010linked immunosorbent assay (ELISA) and quantitative reverse transcription polymerase chain reaction (RT\u2010qPCR), respectively. The Inflammation\u2010Related Principal Component Score (IRPCS) was examined for its association with 3\u2010month functional outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      TREM\u20101 and STAT3 were significantly elevated in acute ischemic stroke (AIS) patients (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.05,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001) and positively correlated (\u03c1 = 0.432,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001). Both biomarkers correlated with the NIHSS at 1 and 3 months and mRS at 3 months (all\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.05). The composite IRPCS showed the strongest association with poor 3\u2010month functional outcome among the tested biomarkers (OR = 2.84, 95% CI: 1.32\u20136.12,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Plasma TREM\u20101 levels were positively correlated with STAT3 expression. The TREM\u20101\u2013STAT3 axis was associated with stroke severity and 3\u2010month functional outcome in AIS patients. These findings should be regarded as exploratory and require validation in larger cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/brb3.71633","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:22:16Z","timestamp":1785914536000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of the TREM\u20101\u2013STAT3 Axis With Stroke Severity and Functional Outcomes in Ischemic Stroke: A Prospective Case\u2010Control Study"],"prefix":"10.1002","volume":"16","author":[{"given":"Haohai","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Neurology The First Affiliated Hospital of Guangxi Medical University  Nanning China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology The First Affiliated Hospital of Guangxi Medical University  Nanning China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangping","family":"He","sequence":"additional","affiliation":[{"name":"Department of Neurology The First Affiliated Hospital of Guangxi Medical University  Nanning China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Neurology The First Affiliated Hospital of Guangxi Medical University  Nanning China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology The First Affiliated Hospital of Guangxi Medical University  Nanning China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2021.09.018"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910\u2010023\u201001282\u20102"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2021.07.016"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113813"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.305628"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2024.07.047"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8197455"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319994"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238\u2010013\u20102084\u20103"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20104422(24)00369\u20107"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2025.04.014"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04889-3"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107212"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.11.019"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2213984"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.06.007"},{"key":"e_1_2_13_18_1","unstructured":"QIAGEN. n.d. \u201cTREM1 Signaling Pathway [GeneGlobe].\u201dhttps:\/\/geneglobe.qiagen.com\/ba\/knowledge\/pathways\/trem1\u2010signaling."},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054\u2010024\u201004798\u20102"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110386"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40779\u2010023\u201000463\u2010x"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345211044681"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408722"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2020.1851897"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.03.043"}],"container-title":["Brain and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/brb3.71633","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/brb3.71633","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/brb3.71633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:04:45Z","timestamp":1789045485000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/brb3.71633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1002\/brb3.71633"],"URL":"https:\/\/doi.org\/10.1002\/brb3.71633","archive":["Portico"],"relation":{},"ISSN":["2162-3279","2162-3279"],"issn-type":[{"value":"2162-3279","type":"print"},{"value":"2162-3279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"2025-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71633"}}